NASDAQ: OBOutbrain Inc Stock
$4.09+0.03 (+0.74%)
Updated Apr 19, 2024
OB Price
$4.09
Fair Value Price
$3.95
Market Cap
$200.63M
52 Week Low
$3.34
52 Week High
$5.95
P/E
20.45x
P/B
0.9x
P/S
0.24x
PEG
0.28x
Dividend Yield
N/A
Revenue
$935.82M
Earnings
$10.24M
Gross Margin
19.7%
Operating Margin
2.32%
Profit Margin
1.1%
Debt to Equity
1.98
Operating Cash Flow
$14M
Beta
1.43
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A
OB Overview
Outbrain Inc. matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. The company's Outbrain Engage solution includes a dashboard to manage and control various aspects of the platform, including content, formats, sources, frequency, and categories of ads delivered on their properties, as well as monetizes the content through customized data-driven advertising. Outbrain was incorporated in 2006 and is headquartered in New York, NY.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OB ($4.09) is overvalued by 3.44% relative to our estimate of its Fair Value price of $3.95 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OB ($4.09) is not significantly undervalued (3.44%) relative to our estimate of its Fair Value price of $3.95 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OB ($4.09) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OB due diligence checks available for Premium users.
Be the first to know about important OB news, forecast changes, insider trades & much more!
OB News
Valuation
OB fair value
Fair Value of OB stock based on Discounted Cash Flow (DCF)
Price
$4.09
Fair Value
$3.95
Overvalued by
3.44%
OB ($4.09) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OB ($4.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OB ($4.09) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
20.45x
Industry
19.34x
Market
40.51x
OB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
OB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.9x
Industry
6.34x
OB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OB price to earnings growth (PEG)
For valuing profitable companies with growth potential
OB is good value based... subscribe to Premium to read more.
PEG Value Valuation
OB's financial health
Profit margin
Revenue
$248.2M
Net Income
$4.1M
Profit Margin
1.6%
OB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$664.6M
Liabilities
$441.6M
Debt to equity
1.98
OB's short-term assets ($401.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OB's short-term assets ($401.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$25.5M
Investing
-$14.1M
Financing
-$5.6M
OB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OB vs Internet Content & Information Stocks
Outbrain Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.